Sitapin Met 50/1000mg Tablet

Sitapin Met 50/1000mg Tablet is a combination medication containing Sitagliptin & Metformin as its active ingredients. Sitagliptin belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors, while Metformin is a biguanide antidiabetic medication. Together, they help regulate blood sugar levels in patients with type 2 diabetes mellitus.

Uses:

Sitapin Met 50/1000mg Tablet is indicated for the treatment of type 2 diabetes mellitus in adults. It is used to help control blood sugar levels in individuals who have not achieved adequate glycemic control with diet and exercise alone. Sitagliptin works by increasing the levels of incretin hormones, which stimulate insulin release and inhibit glucagon secretion, while Metformin decreases glucose production and improves insulin sensitivity.

Dosage:

The usual dosage of Sitapin Met 50/1000mg Tablet is one tablet taken orally, typically once or twice daily, with meals. The dosage may vary depending on individual patient characteristics and the response to treatment. The medication should be taken regularly as prescribed by the healthcare provider. Dosage adjustments may be made based on blood glucose monitoring and the patient’s response to treatment.

Side Effects:

Common side effects associated with Sitapin Met 50/1000mg Tablet may include gastrointestinal symptoms such as nausea, vomiting, diarrhea, and abdominal discomfort. These side effects are usually mild and transient. However, individuals should inform their healthcare provider if they persist or worsen. In rare cases, more serious side effects such as lactic acidosis, pancreatitis, or allergic reactions may occur. Prompt medical attention should be sought if any serious side effects occur.

Precautions:

Before using Sitapin Met 50/1000mg Tablet, individuals should inform their healthcare provider about any pre-existing medical conditions, allergies, or medications they are currently taking. This medication should be used with caution in patients with renal impairment, hepatic dysfunction, or metabolic acidosis. Regular monitoring of renal function and blood glucose levels is recommended during treatment. Pregnant or breastfeeding women should consult a healthcare professional before using this medication.